PCR kit platform that runs complex cancer and chronic disease molecular diagnostics on standard qPCR machines in local hospital labs.
Signatur Biosciences transforms standard qPCR machines into precision diagnostic tools by condensing complex RNA signatures into a single PCR assay, making cancer prognosis and chronic disease diagnostics decentralized, faster, and more affordable. Their kits integrate with existing hospital qPCR infrastructure, reducing turnaround time from three-plus weeks to a few days at a fraction of reference-lab cost, without specialized equipment or expert staff. Signatur Biosciences is a product of Signatur Biosciences.